This is the only pharma stock with double-digit growth in 2022 so far

One must note that the pharma index performed tremendously when the COVID pandemic hit. The pharma index jumped 70 percent between March and December 2020.

Q4 Results Preview: Margins of Pharma companies likely to remain under pressure in the March quarter

According to industry experts, high raw material and logistics costs will reduce EBITDA and PAT margins in the fourth quarter of FY22.

Suven Pharmaceuticals set to acquire Casper Pharma for 155 crore

Suven Pharmaceuticals Limited stated on Tuesday that it will pay  <span class='webrupee'>₹</span>155 crore in cash for Casper Pharma.

As Covid-19 ebbs, what should be your strategy for the pharma sector?

Experts point out as the fears of Covid-19 have ebbed, state-wise budgets have come down this year as temporary hospitals and other state government services related to Covid-19 are not required as of now.

Top Pharma News

markets

This is the only pharma stock with double-digit growth in 2022 so far

markets

markets

markets